Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In SilicoCommunication Published on 2020-10-202022-10-29 Journal: Microorganisms [Category] COVID-19, [키워드] active form active site acute respiratory syndrome antiviral drug clinical trial coronavirus Coronavirus-2 COVID-19 exhibit Favipiravir Genome in silico Infection Influenza influenza A Influenza virus involved ions mechanism MERS-CoV Middle East molecular interaction no interaction nucleotide performed Protein Proteins RdRP replicated Replication respiratory syndrome coronavirus RNA RNA-dependent RNA polymerase SARS-CoV SARS-CoV-2 the SARS-CoV-2 various coronaviruses virus [DOI] 10.3390/microorganisms8101610 PMC 바로가기 [Article Type] Communication
A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling ApproachArticle Published on 2020-09-182022-10-28 Journal: Biology [Category] COVID-19, [키워드] accelerate Adaptive immune response adjuvant Analysis approved B-cell candidate cause caused checked China Comprehensive coronavirus COVID-19 demonstrated development Efficacy Escherichia coli expression globe Helicase help immunization in silico In silico cloning include infections initial Interaction lack linkers molecular molecular dynamics Molecular dynamics simulation molecular interaction Molecular modeling multiepitope vaccine multiple epitope non-structural protein novel Novel coronavirus outbreak pandemic Pathogens peptide polymerase Prophylactic protease protective immunity Repurposed drugs Research SARS-CoV-2 SARS-CoV-2 protein severe respiratory infection simple solution Spike protein Spread stability T-cell epitope three-dimensional structure TLRs Toll-like receptor Treatment triggering urgency Vaccine vaccine construct Vaccine design Vaccine development vaccine production Vaccines virus was used World Health Organization [DOI] 10.3390/biology9090296 PMC 바로가기 [Article Type] Article
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico AnalysisResearch Article Published on 2020-09-172022-10-29 Journal: Journal of Immunology Research [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome analyzed Antigen antigenic antigenic peptide antigenicity B cell binding domain C-terminal caused CD4 CD8 chimeric coronavirus COVID-19 creating effective Efficiency expression humans hypersensitivity reaction immunogenic In silico cloning in viral linear epitope MHC-I MHC-II alleles molecular docking molecular interaction N-terminal novel coronavirus disease nucleocapsid protein pandemic peptide Phosphoprotein predicted provide public health Replication Research RNA Safe SARS-CoV-2 selected Selected epitopes T cell epitope targeting the SARS-CoV-2 the vaccine TLR5 Toxicity translation triggered Vaccine was performed [DOI] 10.1155/2020/2837670 PMC 바로가기 [Article Type] Research Article
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin SystemCell and Developmental Biology Published on 2020-09-162022-10-31 Journal: Frontiers in Cell and Developmental Biology [Category] COVID-19, [키워드] ACE ACE2 activate addition Ang II Ang-(1-7) angiotensin Angiotensin II anti-inflammatory effect AT1 AT1 receptor binding carried cascade cell entry cellular receptor cleavage cleave clinical trial components consequence convert Coronaviridae family coronavirus Course COVID-19 database domain downregulation effort enzyme facilitate human cells insight Interaction Intervention intracellular signaling involved LILACS Lung injury mechanism membrane fusion membrane-bound molecular interaction pandemic pathogen Pathogenesis pathogenesis of COVID-19 pathway Pathways Perspective pro-inflammatory promote RAS RBD receptor Renin renin angiotensin system Research S2 domain SARS-CoV-2 SARS-CoV-2 cell SciELO Scientific community Signaling spike glycoprotein subunits System therapeutic target TMPRSS2 transmembrane treating COVID-19 Treatment vasoconstriction virus [DOI] 10.3389/fcell.2020.559841 PMC 바로가기 [Article Type] Cell and Developmental Biology
Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral ProteaseReview Published on 2020-08-272022-10-30 Journal: Molecules [Category] COVID-19, MERS, [키워드] 3CL 3CL pro acute respiratory syndrome agent approach caused Corona-virus coronavirus CoV COVID-19 CoVs deaths disease global pandemic inhibitor MERS Middle East molecular interaction pandemic proliferation protease respiratory illnesses SARS SARS Coronavirus SARS-CoV SARS-CoV-2 syndrome therapeutic therapeutic agent thought Vaccine variety virus [DOI] 10.3390/molecules25173920 PMC 바로가기 [Article Type] Review
Glycoprotein- and Lectin-Based Approaches for Detection of PathogensReview Published on 2020-08-242022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] Affect approach biochemical assay biosensors Critical death detect detection diagnostics disease glycoprotein Glycoproteins healthcare providers Infectious disease lectins methodology miniaturization molecular interaction Nanotechnology pathogen Pathogens performed point-of-care provide re-emerging disease reagent Research risk robust sensitivity specificity unique [DOI] 10.3390/pathogens9090694 PMC 바로가기 [Article Type] Review
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targetsSARS-CoV-2 메타 인터랙톰은 질병 특이적 자가면역 병태생리 및 치료 표적을 제시합니다Research Article Published on 2020-08-172022-09-11 Journal: F1000Research [Category] MERS, SARS, 신약개발, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed association Asthma asthma) Autoimmune Autoimmune disease Autoimmune diseases Autoimmunity characterized Comorbidities Comorbidity condition contribute Coronary artery coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 Critical diabetes disease Diseases drug expression genetic background help Host human coronavirus human coronaviruses human lung humans identify IFN-β immunological pathway immunological pathways independent inflammatory state interferon interferons Intersection lung Lungs molecular interaction multiple comorbidities multiple comorbidity other respiratory virus Other respiratory viruses pathophysiology performed protein interaction protein-protein interaction reduced Regulation Regulatory repurposing respiratory SARS-CoV-2 SARS-COV-2 infection selected severe acute respiratory syndrome Coronavirus severe coronavirus disease severe COVID-19 significant enrichment statistically significant Therapeutic strategies therapeutic strategy therapeutic target translate Treatment type 2 diabetes type I interferons virus viruses [DOI] 10.12688/f1000research.25593.1 PMC 바로가기 [Article Type] Research Article
Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening ApproachImmunology Published on 2020-07-102022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] ACE2 ACE2 receptor Acetate analyzed anti-inflammatory agents anti-SARS-CoV-2 antiviral drugs approach approved assist binding binding energy binding mode cellular contagious COVID-19 drug drug-repurposing effective Efficiency enzyme FDA host cell host cell receptor identification in silico in vivo inhibiting Lung inflammation molecular docking molecular interaction motif pandemic pathogenic receptor Receptor binding domain receptor binding site Receptor-binding domain repurposing RNA viruses S-protein S-RBD SARS-coronavirus SARS-CoV-2 Screening spike glycoprotein Spike protein Spread targets therapeutic target viral surface Virtual screening virus was used WHO World Health Organization [DOI] 10.3389/fimmu.2020.01664 PMC 바로가기 [Article Type] Immunology
Interaction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic propertiesArticle Published on 2020-06-212022-10-29 Journal: Turkish Journal of Biology [Category] COVID-19, [키워드] 2019 novel coronavirus 2019-nCoV ACE2 addition Analysis binding binding energy cathepsin cathepsin B cathepsin L caused cellular protease coronavirus coronavirus disease COVID-19 cross death docking dose drug-likeness effective evaluated IC50 inhibit Interaction liver cells molecular interaction monoterpene P-glycoprotein pharmacokinetic predicted Receptor binding domain serine protease Spike protein target target protein TMPRSS2 toxic effect transmembrane serine protease [DOI] 10.3906/biy-2005-46 PMC 바로가기 [Article Type] Article
Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and ValidationOriginal Paper Published on 2020-06-192022-10-29 Journal: Jmir Bioinformatics and Biotechnology [Category] COVID-19, [키워드] acute respiratory syndrome Against allele analyzed Antigen antigen processing B cell epitope B-cell Basis caused cDNA cellular complementary complex composed coronavirus COVID-19 CTL cytotoxic T lymphocyte DNA effective elicit ENhance epitope Epitopes expression host cell HTL HTL epitope human cell human transporter associated with antigen processing (TAP) humoral immune responses immune response immunoinformatics in silico In silico methods in vivo interferon leukocyte linear mammalian MEV MEVs molecular molecular docking, molecular dynamics simulation molecular interaction Multi-epitope vaccine multiepitope vaccine nonstructural protein novel coronavirus disease objective Onchocerca volvulus ORF overexpression pandemic positive-sense single-stranded RNA predicted protein sequence proteome reading Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine screened secreted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T lymphocyte the SARS-CoV-2 Toll-like receptor Toll-like receptor (TLR) Vaccine vaccine candidate vaccine candidates Vaccine design validation was used [DOI] 10.2196/19371 PMC 바로가기 [Article Type] Original Paper